Reneo Pharmaceuticals and OnKure Announce Proposed Merger
Global Newswire by Notified: M&A
MAY 13, 2024
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology
Let's personalize your content